ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Celldex Therapeutics Appoints CMO
June 25, 2019Young brings 30 years of experience leading clinical and cross-functional R&D teams. -
Celldex plans life after glembatumumab, cutting 2 more drugs from pipeline
May 16, 2018Still reeling from the failure of its lead breast cancer candidate glembatumumab vedotin last month, Celldex has culled another two pipeline projects and now says it will focus its R&D efforts mainly on two cancer antibodies. -
Stock Dives as Celldex Cuts 20% of Staff After Phase II Breast Cancer Failure
April 26, 2018On April 16, Celldex Therapeutics reported that its Phase IIb trial of glembatumumab vedotin (glemba) failed in a trial of metastatic triple-negative breast cancer
Pharma Sources Insight January 2025
